PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 52 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,605 | -26.7% | 32,882 | +6.7% | 0.00% | – |
| Q2 2023 | $138,672 | -20.5% | 30,816 | +6.7% | 0.00% | – |
| Q4 2022 | $174,429 | -9.6% | 28,879 | -1.0% | 0.00% | – |
| Q3 2022 | $193,000 | +26.1% | 29,179 | -0.0% | 0.00% | – |
| Q2 2022 | $153,000 | -62.9% | 29,189 | -51.2% | 0.00% | – |
| Q1 2022 | $412,000 | -42.6% | 59,820 | +3.7% | 0.00% | – |
| Q4 2021 | $718,000 | -33.0% | 57,676 | +68.1% | 0.00% | – |
| Q3 2021 | $1,072,000 | +23.8% | 34,312 | +13.4% | 0.00% | – |
| Q2 2021 | $866,000 | -35.6% | 30,254 | -2.5% | 0.00% | – |
| Q1 2021 | $1,345,000 | -39.3% | 31,036 | +0.2% | 0.00% | – |
| Q4 2020 | $2,216,000 | – | 30,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |